Used in pharmaceutical research as a key intermediate in the synthesis of bioactive compounds, particularly in the development of CNS-targeted drugs and anti-inflammatory agents. Its structure supports binding to specific enzyme targets due to the electron-withdrawing trifluoromethyl group and the polar oxadiazole ring, enhancing metabolic stability and bioavailability. Also explored in agrochemicals for designing novel pesticides with improved efficacy and environmental profile.